Dimensional Fund Advisors’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$800K Buy
179,890
+23,142
+15% +$104K ﹤0.01% 2872
2026
Q2
$625K Sell
156,748
-37,748
-19% -$104K ﹤0.01% 2941
2026
Q1
$260K Sell
194,496
-78,880
-29% -$157K ﹤0.01% 3034
2025
Q4
$670K Buy
273,376
+28,912
+12% +$126K ﹤0.01% 2926
2025
Q3
$1.64M Buy
244,464
+22,867
+10% +$149K ﹤0.01% 2812
2025
Q2
$1.3M Buy
221,597
+149,955
+209% +$977K ﹤0.01% 2847
2025
Q1
$601K Hold
71,642
– – ﹤0.01% 2974
2024
Q4
$533K Sell
71,642
-101
-0.1% -$676 ﹤0.01% 3025
2024
Q3
$416K Hold
71,743
– – ﹤0.01% 3068
2024
Q2
$477K Sell
71,743
-13,197
-16% -$107K ﹤0.01% 3034
2024
Q1
$1.11M Sell
84,940
-2,084
-2% -$27.8K ﹤0.01% 2907
2023
Q4
$1.11M Sell
87,024
-189,099
-68% -$1.91M ﹤0.01% 2913
2023
Q3
$3.62M Buy
276,123
+200,654
+266% +$3.67M ﹤0.01% 2627
2023
Q2
$1.93M Buy
+75,469
New +$1.95M ﹤0.01% 2797

Other funds holding TMCI

Dimensional Fund Advisors's TMCI Position: Q3 2026 in Review

Dimensional Fund Advisors increased its Treace Medical Concepts (TMCI) stake by 15% in Q3 2026, buying an estimated $104K and bringing the position to 179,890 shares worth $800K. The position accounts for ﹤0.01% of the portfolio, ranked #2872.

Dimensional Fund Advisors first reported a position in TMCI in Q2 2023 and has held it in 14 quarters since. The position peaked at $3.62M in Q3 2023. 116 funds tracked by Wall St. Rank hold TMCI as of Q3 2026.

  • Dimensional Fund Advisors held 179,890 shares of Treace Medical Concepts worth $800K as of Q3 2026.
  • Dimensional Fund Advisors bought 23,142 Treace Medical Concepts shares in Q3 2026, an estimated $104K.
  • Treace Medical Concepts made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #2872 holding.
  • Dimensional Fund Advisors first reported a position in Treace Medical Concepts in Q2 2023 and has held it in 14 quarters since.
  • Dimensional Fund Advisors's Treace Medical Concepts position peaked at $3.62M in Q3 2023.
  • 116 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.